Mark P. Frissora - 15 Feb 2025 Form 4 Insider Report for BIOADAPTIVES, INC. (BDPT)

Role: Director
Signature: /s/ Mark P. Frissora
Issuer symbol: BDPT
Transactions as of: 15 Feb 2025
Net transactions value: +$314,823
Form type: 4
Filing time: 05 May 2025, 21:13:39 UTC
Previous filing: 05 May 2025
Next filing: 23 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FRISSORA MARK P	Director	C/O BIOADAPTIVES, INC., 2620 REGATTA DRIVE, SUITE 102, LAS VEGAS	/s/ Mark P. Frissora	05 May 2025	0001239786

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDPT	Series D Convertible Preferred Stock	Award	$5,005	+455	+13%	$11.00	4,092	15 Feb 2025	Common Stock	45,500		Direct	F1, F2
transaction	BDPT	Series D Convertible Preferred Stock	Award	$5,006	+479	+12%	$10.45	4,571	15 Mar 2025	Common Stock	47,900		Direct	F1, F3
transaction	BDPT	Series D Convertible Preferred Stock	Purchase	$299,807	+39,868	+872%	$7.52	44,439	09 Apr 2025	Common Stock	3,986,800		Direct	F1, F4
transaction	BDPT	Option to Purchase Common Stock	Purchase		+1			1	09 Apr 2025	Common Stock	500,000	$10.00	Direct	F5
transaction	BDPT	Series D Convertible Preferred Stock	Award	$5,005	+501	+1.1%	$9.99	44,940	15 Apr 2025	Common Stock	50,100		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 10% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.
F2	Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1100 on February 14, 2025, times 100.
F3	Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.1045 on March 14, 2025, times 100.
F4	The price per share is based on the average closing price of the Issuer's common stock for the five days prior to the transaction date, less a 20% discount, times 100.
F5	The option to purchase 500,000 shares of the Issuer's common stock was granted to the Reporting Person in connection with the Preferred D Stock Purchase Agreement, dated April 9, 2025, between the Issuer and the Reporting Person. No additional consideration was paid to the Issuer in exchange for such option beyond the consideration paid in exchange for the Series D Convertible Preferred Stock.
F6	Represents shares of Series D Convertible Preferred Stock issued as compensation for board services based on a closing price per share of the Issuer's common stock of $0.0999 on April 15, 2025, times 100.